Fair value measurement for financial reporting and tax valuation may differ and the team at HCVT understands these complexities. We assist our clients with the following reporting requirements:
| ASC 718 | Stock compensation |
| ASC 805 | Business combinations (allocation of the purchase price) |
| ASC 350 | Impairment testing – Indefinite life assets (Step 0 / 1 testing) |
| ASC 360 | Impairment Testing – Long-lived assets |
| ASC 815 | Value of derivatives and hedging instruments |
| ASC 820 | Fair value measurements |
| ASC 825 | Financial instruments (Minority investments) |
| ASC 852 | Fresh-start accounting |
| IRC § 409A | Deferred compensation (stock and options) |
| IRC § 1060 IRC § 338(h)(10) | Allocation of the purchase price by asset type |
| IRC § 165 | Worthless stock deductions |
| IRC § 170 | Charitable contributions |
| IRC § 382 | Net Operating Loss (NOL) limitations |
| IRC § 754 | Value of partnership assets (step-up in basis) |
| IRC § 1202 | Conversion to C-Corp (qualified small business stock) |
| IRC § 1374 | Conversion to S-Corp (built-in gains) |
BEST OF THE BEST
Our passion for excellence, continuous learning, and improvement have garnered HCVT numerous industry accolades. These honors demonstrate the firm’s focus on client service and commitment to maintaining a supportive, employee-centric culture.